Skip to content
$
0.00
0
Cart
Search
(780) 448-0585
IOT.V 0.25 0.00 0.00%
Services
By Application
Anti-Adherence
Anti-Encrustation Testing
Antimicrobials
Environmental Bioburden Monitoring
Facility Water Testing
GMP Analytical Chemistry Testing Services
Medical Device Testing
MIC, MBC, MFC, Toxicology Testing
Microbiology Testing Services
Pharmaceutical & Drug Development
Stability Testing Services
Sterility Testing
By Method
Antimicrobial Effectiveness Testing USP <51>
BEST Assay™ Method
Environmental Bioburden Monitoring
GMP Analytical Chemistry Testing Services
MBEC Assay® Testing
Method Development and Validation Services
MIC, MBC, MFC, Toxicology Testing
By Industry
Compounding Pharmacies
Medical Device Testing
Pharmaceutical & Drug Development
Products
MBEC
InnovoSIL
Resources
Investor Relations
Company
Our Team / History
Careers
Quality
Contact
Contact Us
News
May 23, 2023
Innovotech Reports a Loss for its First Quarter Ended March 31, 2023
May 15, 2023
InnovoSIL TM-1 Antimicrobial Silver Works Against Candida auris and Superbugs
April 25, 2023
Innovotech Reports a Loss for Fiscal 2022
March 31, 2023
Interim Financial Statements & MD&A for period ended 31 March 2023
December 31, 2022
Annual Financial Statements & MD&A For the 2022 year ended December 31
November 15, 2022
Innovotech Reports a Profitable Third Quarter and Sees Its MBEC Assay Plate Used In Space
October 25, 2022
Innovotech Inc. Grants 150,000 Incentive Stock Options and Reports Retirement of a Director
September 30, 2022
Interim Financial Statements & MD&A for period ended 30 Sept 2022
August 16, 2022
Innovotech reports a loss for the first 6 months to June 30th, 2022
August 5, 2022
Stability Studies: Regulatory Quick Links
July 5, 2022
Stability Studies 101
June 30, 2022
Interim Financial Statements & MD&A for period ended 30 June 2022
Page
1
Page
2
Page
3
Page
4
Page
5